Skip to main content
Clinical Trials/ChiCTR-TRC-09000739
ChiCTR-TRC-09000739CompletedUnknown

Combination of Aprepitant and Dexamethasone to Prevent Postoperative Nausea and Vomiting

Departmental1 site in 1 country320 target enrollmentStarted: February 1, 2006Last updated:

Trial Snapshot

Phase
Unknown
Status
Completed
Sponsor
Enrollment
320
Locations
1
Primary Endpoint
Complete response (no vomiting, no nausea, no rescue antiemetic)

Study Overview

Brief Summary

Combination of Aprepitant and Dexamethasone to Prevent Postoperative Nausea and Vomiting

Study Design

Study Type
Interventional
Primary Purpose
随机平行对照
Masking
Double

Eligibility Criteria

Ages
18 to 65 (—)
Sex
Male

Inclusion Criteria

  • All women (age 18-65 years) undergoing open gynecologic surgery will be eligible

Exclusion Criteria

  • (1) Patients had preexisting nausea or vomiting;
  • (2) Patients had received opioids or drugs with known antiemetic properties in the 24 hours before surgery;
  • (3) Pregnant patients;
  • (4) Patients with history of esophageal reflux, opioid or alcohol abuse.

Arms & Interventions

Two groups

Aprepitant Immediately before induction of anesthesia Dexamethasone and a combination of Aprepitant and Dexamethasone

Outcomes

Primary Outcomes

Complete response (no vomiting, no nausea, no rescue antiemetic)

Secondary Outcomes

  • QoR,FLIE questionnaire, Pain and nausea score

Investigators

Sponsor
Departmental

Study Sites (1)

Loading locations...

Similar Trials